X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WYETH LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WYETH LTD ABBOTT INDIA/
WYETH LTD
 
P/E (TTM) x 35.0 27.7 126.1% View Chart
P/BV x 10.1 5.3 189.1% View Chart
Dividend Yield % 0.6 1.3 47.6%  

Financials

 ABBOTT INDIA   WYETH LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-17
WYETH LTD
Mar-13
ABBOTT INDIA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs5,1901,044 496.9%   
Low Rs4,351818 531.9%   
Sales per share (Unadj.) Rs1,382.9298.6 463.2%  
Earnings per share (Unadj.) Rs130.257.2 227.4%  
Cash flow per share (Unadj.) Rs137.958.4 236.1%  
Dividends per share (Unadj.) Rs40.0017.00 235.3%  
Dividend yield (eoy) %0.81.8 45.9%  
Book value per share (Unadj.) Rs652.7249.5 261.6%  
Shares outstanding (eoy) m21.2522.72 93.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.1 110.6%   
Avg P/E ratio x36.616.3 225.2%  
P/CF ratio (eoy) x34.615.9 217.0%  
Price / Book Value ratio x7.33.7 195.8%  
Dividend payout %30.729.7 103.5%   
Avg Mkt Cap Rs m101,37321,157 479.2%   
No. of employees `0003.10.5 626.6%   
Total wages/salary Rs m3,453400 863.2%   
Avg. sales/employee Rs Th9,531.913,787.4 69.1%   
Avg. wages/employee Rs Th1,119.9813.0 137.7%   
Avg. net profit/employee Rs Th897.32,643.3 33.9%   
INCOME DATA
Net Sales Rs m29,3876,783 433.2%  
Other income Rs m576353 163.5%   
Total revenues Rs m29,9637,136 419.9%   
Gross profit Rs m3,9731,617 245.7%  
Depreciation Rs m16427 617.7%   
Interest Rs m206 370.9%   
Profit before tax Rs m4,3651,938 225.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,598632 252.8%   
Profit after tax Rs m2,7671,301 212.7%  
Gross profit margin %13.523.8 56.7%  
Effective tax rate %36.632.6 112.2%   
Net profit margin %9.419.2 49.1%  
BALANCE SHEET DATA
Current assets Rs m18,9066,984 270.7%   
Current liabilities Rs m6,2972,056 306.3%   
Net working cap to sales %42.972.6 59.1%  
Current ratio x3.03.4 88.4%  
Inventory Days Days6299 62.6%  
Debtors Days Days2224 90.4%  
Net fixed assets Rs m1,159244 474.3%   
Share capital Rs m213227 93.5%   
"Free" reserves Rs m13,6575,441 251.0%   
Net worth Rs m13,8695,668 244.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m20,6387,901 261.2%  
Interest coverage x215.0353.3 60.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.9 165.9%   
Return on assets %13.516.5 81.7%  
Return on equity %19.922.9 86.9%  
Return on capital %31.634.0 92.9%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m015 0.0%   
Fx outflow Rs m02,677 0.0%   
Net fx Rs m0-2,662 0.0%   
CASH FLOW
From Operations Rs m3,072923 332.8%  
From Investments Rs m-1,554317 -490.4%  
From Financial Activity Rs m-898-481 186.6%  
Net Cashflow Rs m621759 81.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 7.2 1.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 30.4 56.3%  
Shareholders   18,270 21,978 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  MERCK LTD  GSK PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Energy and IT Stocks Witness Buying(12:30 pm)

Stock markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 25, 2018 12:57 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ALKEM LABORATORIES COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS